623 related articles for article (PubMed ID: 28619074)
1. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
[TBL] [Abstract][Full Text] [Related]
2. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
[TBL] [Abstract][Full Text] [Related]
3. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
[TBL] [Abstract][Full Text] [Related]
4. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
[TBL] [Abstract][Full Text] [Related]
5. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
Stemberger S; Poewe W; Wenning GK; Stefanova N
Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
[TBL] [Abstract][Full Text] [Related]
6. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease.
Williams GP; Marmion DJ; Schonhoff AM; Jurkuvenaite A; Won WJ; Standaert DG; Kordower JH; Harms AS
Acta Neuropathol; 2020 May; 139(5):855-874. PubMed ID: 31993745
[TBL] [Abstract][Full Text] [Related]
7. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
[TBL] [Abstract][Full Text] [Related]
8. IFNγ drives neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy.
Corbin-Stein NJ; Childers GM; Webster JM; Zane A; Yang YT; Mudium N; Gupta R; Manfredsson FP; Kordower JH; Harms AS
Acta Neuropathol Commun; 2024 Jan; 12(1):11. PubMed ID: 38238869
[TBL] [Abstract][Full Text] [Related]
9. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Mandler M; Valera E; Rockenstein E; Mante M; Weninger H; Patrick C; Adame A; Schmidhuber S; Santic R; Schneeberger A; Schmidt W; Mattner F; Masliah E
Mol Neurodegener; 2015 Mar; 10():10. PubMed ID: 25886309
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
[TBL] [Abstract][Full Text] [Related]
11. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R
PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527
[TBL] [Abstract][Full Text] [Related]
12. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
[TBL] [Abstract][Full Text] [Related]
13. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
[TBL] [Abstract][Full Text] [Related]
14. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
[TBL] [Abstract][Full Text] [Related]
15. Pathological Endogenous α-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy.
Kaji S; Maki T; Kinoshita H; Uemura N; Ayaki T; Kawamoto Y; Furuta T; Urushitani M; Hasegawa M; Kinoshita Y; Ono Y; Mao X; Quach TH; Iwai K; Dawson VL; Dawson TM; Takahashi R
Stem Cell Reports; 2018 Feb; 10(2):356-365. PubMed ID: 29337114
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
[TBL] [Abstract][Full Text] [Related]
17. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
[TBL] [Abstract][Full Text] [Related]
18. Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.
Hasegawa T; Baba T; Kobayashi M; Konno M; Sugeno N; Kikuchi A; Itoyama Y; Takeda A
Neurochem Int; 2010 Dec; 57(8):857-66. PubMed ID: 20849899
[TBL] [Abstract][Full Text] [Related]
19. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.
Spencer B; Valera E; Rockenstein E; Trejo-Morales M; Adame A; Masliah E
Mol Neurodegener; 2015 Sep; 10():48. PubMed ID: 26394760
[TBL] [Abstract][Full Text] [Related]
20. The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions.
Radford R; Rcom-H'cheo-Gauthier A; Wong MB; Eaton ED; Quilty M; Blizzard C; Norazit A; Meedeniya A; Vickers JC; Gai WP; Guillemin GJ; West AK; Dickson TC; Chung R; Pountney DL
Mol Cell Neurosci; 2015 Mar; 65():68-81. PubMed ID: 25731829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
